Chicago-based crypto exchange Bitnomial has launched monthly futures contracts for Injective (INJ), the first US-regulated derivatives product for the Web3 financial ecosystem's native token. These contracts settle in INJ with monthly expiries, allowing traders price exposure without holding the asset directly. They can be margined in crypto or U.S. dollars via Bitnomial's clearinghouse.
This launch initiates a six-month track record that could support a spot exchange-traded fund under SEC listing rules. Institutional clients gain immediate access, with retail trading expected soon on Bitnomial's Botanical platform. The exchange also plans perpetual futures and options for INJ.
Injective operates on a Layer 1 blockchain designed for financial applications, featuring an on-chain order book and cross-chain connectivity. Bitnomial, regulated by the CFTC, specializes in crypto futures and options.